24 research outputs found

    Cooking methods of Cavia porcellus meat

    No full text
    In this study the effect of culinary technique and cooking times on Cavia porcellus meat consumers’ preference was analyzed, in order to determinate the acceptance of this rodent as a food resource. Two culinary techniques were used: roast (2, 3 and 4 min) and scalded (10, 15 and 20 min). Infraspinatus, deltoid and minor round muscles were considered as the experimental unit. To evaluate the sensory variables (smell, taste, juiciness and tenderness) meat samples were evaluated by a group of 20 consumers using a hedonic scale of structured satisfaction of 4 points and analyzed with a Friedman Test. The results indicate that Cavia porcellus meat is a viable option to be part of the food supply in Mexico since in all the sensory variables obtained positive ratings in the hedonic scale. Now it is necessary to explore the potential consumers and ways to present the meat of C. porcellus to consolidate the research

    Operational forecasting of daily summer maximum and minimum temperatures in the Valencia Region

    Get PDF
    Extreme-temperature events have a great impact on human society. Thus, knowledge of summer temperatures can be very useful both for the general public and for organizations whose workers operate in the open. An accurate forecasting of summer maximum and minimum temperatures could help to predict heatwave conditions and permit the implementation of strategies aimed at minimizing the negative effects that high temperatures have on human health. The objective of this work is to evaluate the skill of the regional atmospheric and modelling system (RAMS) model in determining daily summer maximum and minimum temperatures in the Valencia Region. For this, we have used the real-time configuration of this model currently running at the Centro de Estudios Ambientales de Mediterráneo Foundation. This operational system is run twice a day, and both runs have a 3-day forecast range. To carry out the verification of the model in this work, the information generated by the system has been broken into individual simulation days for a specific daily run of the model. Moreover, we have analysed the summer forecast period from 1 June to 31 August for 2007, 2008, 2009 and 2010. The results indicate good agreement between observed and simulated maximum temperatures, with RMSE in general near 2 °C both for coastal and inland stations. For this parameter, the model shows a negative bias around −1.5 °C in the coast, while the opposite trend is observed inland. In addition, RAMS also shows good results in forecasting minimum temperatures for coastal locations, with bias lower than 1 °C and RMSE below 2 °C. However, the model presents some difficulties for this parameter inland, where bias higher than 3 °C and RMSE of about 4 °C have been found. Besides, there is little difference in both temperatures forecasted within the two daily RAMS cycles and that RAMS is very stable in maintaining the forecast performance at least for three forecast days

    Grado de conocimiento, tratamiento y control de la hipertensión arterial, hipercolesterolemia y diabetes mellitus en la población general adulta

    Get PDF
    ObjetivosEstimar la prevalencia de los principales factores de riesgo cardiovascular (FRCV) tras la confirmación diagnóstica con el criterio clínico. Analizar el grado de su conocimiento y control, y evaluar la asociación de los FRCV entre sí, estimando qué población es susceptible de intervención.DiseñoEstudio observacional, descriptivo,transversal.EmplazamientoEstudio poblacional realizado en el Área de Salud número 20 de la Comunidad Valenciana (comarca de la Vega Baja del río Segura)PacientesPersonas con ≥ 20 años residentes en dicha área. Muestreo aleatorio polietápico proporcional con definición de cuotas muestrales según el tipo de residencia. Tamaño muestral: 2.550 personas (falta de respuesta en la primera fase en el 26%). Segunda fase del estudio: se realiza la confirmación clínica de los 374 casos detectados de hipertensión arterial (HTA), los 126 de hipercolesterolemia (HCOL) y los 33 de diabetes mellitus (DM).MedicionesSe realiza una entrevista a los pacientes detectados para las tomas de presión arterial a los hipertensos y para practicar la extracción sanguínea a hipercolesterolémicos y diabéticos. Se han utilizado los criterios diagnósticos preconizados por los últimos consensos.ResultadosParticipan 1.886 personas (78,1%). Prevalencias halladas: HTA total, 42 ± 2,2%; diagnosticada, 11,7 ± 1,4%; HCOL total, 26,6 ± 2%; DM total, 9,5 ± 1,3%; tabaquismo: 33,6 ± 2,1% y obesidad: 31,6 ± 2,1%. Grado de control: HTA, 8,6%; HCOL, 21,7%; DM, 56,1%. Asociación de FRCV: el 25,5% no presenta hipertensión, hipercolesterolemia ni fuma.ConclusionesElevada prevalencia FRCV en nuestra área frente a los resultados publicados de ámbito nacional. El tabaquismo resulta menos frecuente que en el resto del país. El grado de control es escaso y la asociación de los FRCV principales para cardiopatía isquémica reflejan que cerca del 75% de la población debe ser intervenida.ObjectivesTo calculate the prevalence of the main cardiovascular risk factors (CVRF) after diagnostic confirmation using clinical criteria. To analyse the degree of understanding and monitoring of these factors and to evaluate the association of CVRF with each other, so estimating who is susceptible to intervention.DesignCross-sectional, descriptive, observational study.SettingPopulation study conducted in Health Area 20 of the Community of Valencia (county of the Low Plain of the River Segura). Patients. People who had lived in this Area for ³20 years. Proportional, multi-stage randomised sampling with definition of sample quotas according to type of residence. Sample size: 2550 people (no reply in first stage: 26%). The second stage involved the clinical confirmation of those identified as suffering from hypertension (HT) (374), hypercholesterolaemia (HCOL) (126), and diabetes (DM) (33).MeasurementsPatients identified were interviewed for taking blood pressure in the case of those with HT, and blood samples in the case of those with HCOL and DM. The diagnostic criteria recommended by the latest consensus were used.Results1886 people (78.1%) took part. Prevalences found: total HT 42±2.2%, diagnosed: 11.7±1.4; total HCOL 26.6±2%; total DM 9.5±1.3%.Tobacco dependency was 33.6±2.1% and Obesity: 31.6±2.1%. Degree of control: HT, 8.6%; HCOL, 21.7%; DM, 56.1%. Association of CVR factors with each other: 25.5% had neither HT nor HCOL and did not smoke.ConclusionsHigh prevalence of CVRF in our area, compared with published national findings.Tobacco dependency is less common than at national level. The degree of control is very low and the association of the main CVRF factors for ischaemic cardiopathy reflect that nearly 75% of the population requires a preventive intervention

    Identificación de las variables de influencia en los tiempos de espera en atención especializada

    No full text
    Objetivo: Identificar, mediante análisis de regresión múltiple, las variables de influencia en el tiempo de acceso a atención especializada (listas de espera), y analizar las zonas de salud con tiempo de acceso elevado, en función de las mencionadas variables. Diseño: Estudio descriptivo transversal, retrospectivo, del tiempo de acceso a atención especializada, durante los años 1997 y 1998. Emplazamiento: Área 20 de la Conselleria de Sanitat de la Comunidad Valenciana; 12 zonas de salud; 204.424 habitantes. Intervenciones: Se recogen variables de demanda (tipo de municipio, envejecimiento e índices de dependencia poblacional, porcentaje de pensionistas), de oferta (edad, sexo, formación y situación laboral del médico, tamaño del cupo) y de consumo (porcentaje de derivación a especializada por mil habitantes, tiempo medio de acceso a especializada (en días naturales) por zona y año, frecuentación y presión asistencial. Se construye un modelo de regresión múltiple por eliminación (hacia atrás), tomando como variable dependiente el tiempo medio de espera (TE) y como independiente el resto. La ecuación resultante permitió calcular el TE esperado por zona de salud y la desviación de su TE real sobre el esperado. Se consideró zona con TE elevado cuando su desviación superaba la media más una desviación estándar de dicha distribución. Resultados: El tiempo de espera medio para acceder a especializada fue de 37 días en 1997 y 34 días en 1998. Existe una correlación significativa (p < 0,005) entre el TE y el porcentaje de población menor de 14 años (r = -0,693), el porcentaje de población entre 14 y 65 años (r = 0,517), la frecuentación (r = 0,689) y la población de costa (r = 0,470). Nuestro modelo final incluyó: el porcentaje de población menor de 14 años, la frecuentación y la población de costa (F = 41,803; p < 0,000; r = 0,945; r² = 0,893). Se identificaron tres zonas (37,5%) con TE elevado. Conclusiones: La frecuentación, el porcentaje de población pediátrica y la proximidad a la costa guardan una estrecha correlación con el tiempo de acceso a atención especializada, lo cual condiciona las listas de espera

    Oral pharmacokinetically enhanced co-amoxiclav 2000/125 mg, twice daily, compared with co-amoxiclav 875/125 mg, three times daily, in the treatment of community-acquired pneumonia in European adults

    No full text
    OBJECTIVES: Pharmacokinetically enhanced co-amoxiclav 2000/125 mg was designed to achieve high serum concentrations of amoxicillin over the 12 h dosing interval to eradicate Streptococcus pneumoniae with amoxicillin MICs of at least 4 mg/L. METHODS: This randomized, double-blind, double-dummy, multicentre study compared the efficacy and safety of oral co-amoxiclav 2000/125 mg twice daily versus co-amoxiclav 875/125 mg three times daily, for 7 or 10 days, in the treatment of community-acquired pneumonia (CAP). RESULTS: The per-protocol (PP) population at follow-up (Days 18-39) comprised 114 patients receiving co-amoxiclav 2000/125 mg and 116 receiving co-amoxiclav 875/125 mg. Clinical success at follow-up (primary efficacy endpoint) in the clinical PP population was 94.7% (108/114) for co-amoxiclav 2000/125 mg versus 88.8% (103/116) for co-amoxiclav 875/125 mg [treatment difference (TD) = 5.9%, 95% CI: 1.1, 13.0]. Bacteriological success in the bacteriology PP population at follow-up was 85.0% (17/20) for co-amoxiclav 2000/125 mg versus 77.3% (17/22) for co-amoxiclav 875/125 mg (TD = 7.7%, 95% CI: 15.8, 31.2). Penicillin-resistant S. pneumoniae (PRSP) were isolated in three patients (including two with bacteraemia) in the co-amoxiclav 2000/125 mg group (amoxicillin MICs 8 mg/L, penicillin MICs 4 mg/L) and one in the comparator group; all were clinical and bacteriological successes. Co-amoxiclav 2000/125 mg and co-amoxiclav 875/125 mg were associated with adverse events leading to withdrawal in 6.3% and 6.2% of patients, respectively. CONCLUSIONS: Co-amoxiclav 2000/125 mg twice daily was at least as effective clinically as co-amoxiclav 875/125 mg three times daily in the treatment of CAP. Although few patients in this study had PRSP infection, 3/3 were successfully treated with co-amoxiclav 2000/125 mg

    Estudio de prevalencia de factores de riesgo cardiovascular en un área de salud

    Get PDF
    ObjetivoEstimar la prevalencia de los factores de riesgo cardiovascular: hipertensión arterial (HTA), hipercolesterolemia, diabetes mellitus (DM), obesidad y tabaquismo en el Área de Salud 20 de la Comunidad Valenciana.DiseñoEstudio observacional descriptivo transversal.EmplazamientoEstudio poblacional realizado en el Área de Salud 20 de la Comunidad Valenciana (comarca de la Vega Baja del río Segura).PacientesPersonas 3 20 años de edad residentes en dicha área. Muestreo aleatorio polietápico proporcional con definición de cuotas muestrales según tipo de residencia (urbano, periurbano y rural), según grupos de edad y sexo. Tamaño muestral calculado de 2.550 personas. Se excluyen las embarazadas y las personas diagnosticadas de enfermedad psíquica o física incapacitante (n = 134). Se incluye el resto (n = 2.416).MedicionesMediante entrevista personal se cumplimenta un cuestionario y se realiza una exploración física básica. Posteriormente se practica una extracción sanguínea. Se recogen las siguientes variables: filiación, datos socioeconómicos, enfermedades previas (cardiovasculares, HTA, hipercolesterolemia, DM), hábito tabáquico, índice de masa corporal, presión arterial, hemograma y bioquímica estándar. Se han utilizado los criterios diagnósticos preconizados por el último consenso para cada factor.ResultadosDe las 2.416 personas elegibles, participan 1.886 (78,06%). Prevalencias halladas: HTA conocida: 30,3 ± 2,1% (mujeres: 34,1 ± 2,9%, varones: 25,8 ± 2,9%); hipercolesterolemia conocida: 22,6 ± 1,9%; diabetes conocida: 8,4 ± 1,2%; tabaquismo: 33,6 ± 2,1% (mujeres: 25,4 ± 2,7%; varones: 42,2 ± 3,3%; grupo de edad 20–39 años: 56,9 ± 3,8%), y obesidad: 31,6 ± 2,1% (mujeres: 34,6 ± 2,9%; varones: 28,1 ± 3%; grupo de edad 3 60 años: 46,7 ± 3,9%). Se presentan los datos de detección.ConclusionesSe han encontrado prevalencias elevadas de hipertensión arterial, hipercolesterolemia, diabetes y obesidad, superiores a las halladas en el ámbito nacional. El tabaquismo es menos frecuente, aunque en los jóvenes es muy prevalente. La hipertensión conocida y la obesidad son más prevalentes en mujeres que en varones.ObjectiveTo calculate the prevalence of cardiovascular risk factors: hypertension, hypercholesterolaemia, diabetes mellitus (DM), obesity and tobacco dependency, in Health Area 20 of the Community of Valencia.DesignCross-sectional, descriptive, observational study.SettingPopulation study carried out in Health Area 20 of the Community of Valencia (Vega Baja del río Segura county).Patients≥20 years-old people, living in this area. Multi-stage randomised sample proportional to the definition of sample quotas according to the kind of residence (urban, peri-urban or rural), age groups and sex. Calculated sample size of 2550 people. Pregnant women and people diagnosed with incapacitating psychiatric or physical illnesses (134) were excluded. The rest (2416) were included.MeasurementsA questionnaire was filled out in a face-to-face interview and a basic physical examination was made. A blood sample was taken. The following variables were recorded: personal details, social and economic details, previous illnesses (cardiovascular, hypertension, hypercholesterolaemia, DM), tobacco habit, Body Mass Index, blood pressure, haemogram and standard biochemical test. The most recently agreed and recommended diagnostic criteria were used for each factor.Results1886 people of the 2416 eligible took part (78.06%). Prevalence was as follows: hypertension, 30.3±2.1% (women, 34.1±2.9%; men, 25.8±2.9%); hypercholesterolaemia, 22.6±1.9%; diabetes, 8.4±1.2%; tobacco dependency, 33.6±2.1% (women, 25.4±2.7%; men, 42.2±3.3%; 20–39 years old age-group, 56.9±3.8%), and obesity, 31.6±2.1% (women, 34.6±2.9%; men, 28.1±3%; age group ≥60 years old, 46.7±3.9%). Detection data were shown.ConclusionsHigh presence of hypertension, hypercholesterolaemia, diabetes and obesity, greater than the country-wide level. Tobacco dependency was less common, though very high in young people. Known hypertension and obesity are more common in women than men
    corecore